Keyphrases
Parkinson's Disease
100%
Functional Connectivity
31%
Gait Impairment
27%
Dementia
24%
Resting-state Functional Connectivity (rs-FC)
22%
Dystrophin
21%
Movement Disorders
21%
Duchenne muscular Dystrophy
20%
Vermis
20%
Network Effects
18%
Positron Emission Tomography
18%
Functional Networks
18%
Reducing Body Myopathy
18%
LIM Domain
13%
Pathophysiology
12%
Binding Potential
12%
Cerebral Cortex
12%
Exon 6
11%
Alternative Translation Initiation
11%
Point mutation
11%
Split-half
10%
Striatal
10%
Distributed Brain Network
10%
Myopathy
10%
Cognitive Correlates
9%
Levodopa Response
9%
Neocortical
9%
Cognitive-motor
9%
New Drug Targets
9%
Lewy Pathology
9%
Clinical Subtypes
9%
Pathophysiologic
9%
Functional Imaging
9%
Parkinson's Disease Dementia
9%
Motor Deficits
9%
Cognitive Reserve
9%
Human Brain
9%
Motor Cortex
9%
Truncation Point
9%
Proteomic Identification
9%
Test-retest Reliability
9%
Clinical Characterization
9%
Z-domain
9%
Amyloid Pathology
9%
Genetic Characterization
9%
White Matter
9%
Gait Score
9%
Age-dependent
9%
PET Quantification
9%
Vesicular Acetylcholine Transporter (VAChT)
9%
Neuroscience
Parkinson's Disease
96%
Functional Connectivity
31%
Resting-State Functional Connectivity
24%
Stereotypic Movement Disorder
19%
Positron Emission Tomography
16%
Brain Network
10%
Cerebral Cortex
10%
Positron Emission Tomography
9%
Fluorine-18
9%
Lewy Body
9%
2,5-Dimethoxy-4-iodoamphetamine
9%
Functional Imaging
9%
FHL1
9%
Muscle Disorder
9%
Amyloid Protein
9%
Magnetic Resonance Imaging
8%
Clinical Dementia Rating
6%
Cognitive Disorders
5%
Cognitive Function
5%